Market Tracker

06/23 5:16pm ET

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

7.51
Delayed Data
As of Jun 23
 -0.09 / -1.18%
Today’s Change
4.00
Today|||52-Week Range
11.72
-13.08%
Year-to-Date
No recent news for Progenics Pharmaceuticals Inc.

Today’s Trading

Previous close7.60
Today’s open7.60
Day’s range7.30 - 7.60
Volume962,349
Average volume (3 months)1,326,933
Market cap$527.4M
Dividend yield--
Data as of 3:59pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-564.00%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)+700.24%
P/E ratio75.1
Price/Sales8.73
Price/Book5.03

Competitors

 Today’s
change
Today’s
% change
ITCIIntra-Cellular Thera...+0.64+5.56%
ACIUAC Immune Ltd+0.27+2.96%
RARXRa Pharmaceuticals I...+0.01+0.04%
CTMXCytomX Therapeutics ...+0.41+2.85%
Data as of 4:00pm ET, 06/23/2017

Financials

Next reporting dateAugust 10, 2017
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$69.4M
Annual profit (last year)$10.8M
Net profit margin15.56%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mark Robert Baker
CFO, Principal Accounting Officer &
Senior VP
Patrick Fabbio
Corporate headquarters
Tarrytown, New York

Forecasts